
MUMBAI, Nov. 23 (UPI) -- Atorvastatin pills, the generic version of the drug Lipitor, will be recalled due to possible glass contamination, its Indian manufacturer announced.
Ranbaxy Laboratories Ltd., India's largest pharmaceutical company, said Friday small particles of glass, less than 1 millimeter (.039 inch) in size, may be in select batches of 10 milligram, 20 milligram and 409 milligram-dosage packages of 90-count and 500-count bottles.
Statins, or lipid-lowering drugs, are among the most commonly prescribed medications in the United States, used to lower the risk of heart attack, stroke and other cardiovascular ailments, CBS News said. Atorvastatin is the largest selling statin.
The drug will be voluntarily recalled in the United States while the company investigates the issue, the financial website Marketwatch said Friday.
"The investigation is expected to be completed within two weeks, and thereafter the company expects to resume supplies," Ranbaxy Pharmaceutical said in a government regulatory filing.
|
|
|
|
|
|
| Additional Business News Stories | |
BRUSSELS, May 22 (UPI) --
The European Union will carefully weigh the risks of shale gas development this year but also needs to stem high energy prices, the EU's energy chief says.
|
SANTIAGO, Chile, May 21 (UPI) --
More than $4 billion of cash reserved for Chilean military procurement remains unspent because of mysterious workings of funding arrangements.
|
Properties repossessed by lenders in the first quarter took an average of 477 days to complete the foreclosure process, up from 414 days in the previous...
|
Nobody likes spending cuts but the champion of that attitude is clearly President Barack Obama, who seems to have a very clear pain-avoidance agenda.
|
| Stories | Photos | Comments |
View Caption